Pharma Journalist -

AstraZeneca has entered into a licence agreement with RQ Biotechnology Ltd (RQ Bio) for a portfolio of early-stage monoclonal antibodies (mAbs) targeted against SARS-CoV-2, the virus…
Read More...

Pfizer Inc. and BioNTech SE announced the U.S. Food and Drug Administration (FDA) expanded emergency use authorization (EUA) to include a booster dose after completion of the primary…
Read More...

Sernova Corp. a clinical-stage company and leader in regenerative medicine cell therapeutics, and Evotec SE a global pharmaceutical and life science company, and leading developer of…
Read More...

SAE Media Group’s 3rd Annual Conference Pre-Filled Syringes San Francisco September 19 - 20, 2022 | San Francisco, CA, USA http://www.prefilled-sanfrancisco.com/PR1…
Read More...

Zealand Pharma A/S a biotechnology company focused on the discovery and development of innovative peptide-based medicines, announced it has entered into an asset purchase agreement with…
Read More...

Proscia, a leader in digital and computational pathology solutions, has introduced an automated quality control application that leverages artificial intelligence to improve quality and…
Read More...

SIMCERE PHARMA announced that SIM0417, a candidate drug against SARS-Cov-2, for which the Company holds license from Shanghai Institute of Materia Medica (SIMM) and Wuhan Institute of…
Read More...

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, announced the availability of ultrarapid whole genome sequencing (urWGS) through PerkinElmer Genomics.…
Read More...

Proteros biostructures GmbH (“Proteros”), an expert in integrated structure-based drug discovery, announces an expansion of its collaboration with AstraZeneca focused on the discovery…
Read More...

Kriya Therapeutics, Inc., a fully integrated gene therapy company pioneering novel technologies and therapeutics, announced a $270 Million Series C financing. The financing was led by…
Read More...